Barnik Invest’s Portfolio Company, Cell4Cure, Forges Strategic Partnership with Bartlett Hill Partners to lead North American Business Development activities

Solna, Stockholm, Sweden – March 12, 2025 – Barnik Invest’s Portfolio Company, Cell4Cure AB, a pioneering Swedish biotech company developing innovative immune tolerance therapies, last week announced its strategic partnership with Bartlett Hill Partners LLC, a leading advanced therapies consulting group based in Boston, to spearhead its North American business development initiatives. Cell4Cure’s proprietary antigen-specific […]